New Key Statistics Module, Z-Score and F-Score
OTCPK:HLTRF Key Ratios
| Market Cap $ M | 75.01 |
| Enterprise Value $ M | 125.56 |
| P/E(ttm) | -- |
| PE Ratio without NRI | -- |
| Forward PE Ratio | -- |
| Price/Book | 0.90 |
| Price/Sales | 1.29 |
| Price/Free Cash Flow | 6.13 |
| Price/Owner Earnings | -- |
| Payout Ratio % | -- |
| Revenue (TTM) $ M | 58.00 |
| EPS (TTM) $ | -0.75 |
| Beneish M-Score | -3.57 |
| 10-y EBITDA Growth Rate % | -- |
| 5-y EBITDA Growth Rate % | -10.00 |
| y-y EBITDA Growth Rate % | 9.80 |
| EV-to-EBIT | -12.44 |
| EV-to-EBITDA | 7.44 |
| PEG | -- |
| Shares Outstanding M | 31.79 |
| Net Margin (%) | -40.92 |
| Operating Margin % | -16.42 |
| Pre-tax Margin (%) | -34.55 |
| Quick Ratio | 1.69 |
| Current Ratio | 2.02 |
| ROA % (ttm) | -11.63 |
| ROE % (ttm) | -25.07 |
| ROIC % (ttm) | -6.52 |
| Dividend Yield % | -- |
| Altman Z-Score | -0.65 |
HLTRF Number of Guru Trades
HLTRF Volume of Guru Trades
Gurus Latest Trades with OTCPK:HLTRF
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
OTCPK:HLTRF is held by these investors
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
HLS Therapeutics Inc Insider Transactions
No Available Data
News about OTCPK:HLTRF
Total 0- 1
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers